Figure 3
From: The impact of COVID-19 on microRNA and CD marker expression in AML patients
Analysis of microRNA expression levels in AML patients concerning COVID-19. (A) Sample size of COVID-19 in AML patients and healthy control. (B) microRNA expression patterns in AML and its association with COVID-19.
